Crispr News

• CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
  September 25, 2022
• Recession Fears Increasing: Here's the Best Stock to Buy Right Now - The Motley Fool
  September 24, 2022
• Redirecting meiotic recombination by CRISPR–Cas-mediated chromosome engineering - Nature.com
  September 23, 2022
• CRISPR could make testing for SARS-CoV-2 fast and easy - Futurity: Research News
  September 23, 2022
• Biotechnological Plant Breeding and CRISPR Plants Market 2022 Demand Rising with Key Players, Comprehensive An - openPR
  September 23, 2022
• Potential of precision genome editing in treating inherited retinal diseases: Improvements in technology and delivery techniques could revolutionize treatment of genetic disorders of vision - Science Daily
  September 23, 2022
• Biden's Covid declaration, twilight of the SPAC, & genome editing 2.0 - STAT
  September 22, 2022
• Why Is It the Right Time to Invest in Pharma Stocks? - FinSMEs
  September 22, 2022
• There’s New Proof Crispr Can Edit Genes Inside Human Bodies - WIRED
  September 22, 2022
• Mammoth Biosciences Named as an “Endpoints 11” Most Promising Startup of 2022 - Business Wire
  September 22, 2022
• CRISPR-Based HIV Gene Therapy Administered To First Human Patient - IFLScience
  September 22, 2022
• Researchers advance CRISPR technology to replicate human diseases with unprecedented accuracy - Medical Xpress
  September 21, 2022
• Juul Sues FDA For Withholding Scientific Reviews Behind E-Cig Ban - Kaiser Health News
  September 21, 2022
• Vertex CEO Interview on Future Growth, CRISPR Cures - Business Insider
  September 21, 2022
• Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges - Nature.com
  September 21, 2022
• After early wins, CRISPR gene editing is about to get a lot harder - STAT
  September 21, 2022
• Plant breeding: Using 'invisible' chromosomes to pass on packages of positive traits: KIT researchers use CRISPR/Cas to suppress chromosomes and prevent genetic exchange - Science Daily
  September 20, 2022
• CRISPR Technology Market Report 2022: Widespread Potential Applications Drives Opportunities - ResearchAndMarkets.com - Business Wire
  September 20, 2022
• New CRISPR startup seeks to fix diseases caused by large DNA errors - STAT
  September 20, 2022
• New reversible gene-editing technique may be safer and more reliable than standard CRISPR - Genetic Literacy Project
  September 20, 2022